Source: Geron Corporation
Date: January 17, 2007
Summary:
Geron Corporation today reported that studies show GRNOPC1, the company’s human embryonic stem cell (hESC)-based neural stem cell therapy, produces multiple nerve growth factors, proteins that stimulate the survival and regeneration of neurons damaged during spinal cord injury.
No comments:
Post a Comment